Ligand PharmaceuticalsvsMerck & Company

LGND and MRK stock compared: price, dividend, valuation and results, from SEC filings.

LGND

Ligand Pharmaceuticals Incorporated

$286.94

Value $5.7B

-3.94%
LGND's page

MRK

Merck & Company, Inc.

$132.81

Value $328B

-3.61%
MRK's page

Ligand Pharmaceuticals (LGND) has a market value of $5.7B and Merck & Company (MRK) $328B. Over the last year, with dividends, LGND moved +38.6% and MRK +41.8%. The P/E is 111.2 for LGND and 133.9 for MRK. Dividend yield: LGND none, MRK 2.56%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    LGND$5.7B

    MRK$328B

    MRK is 57 times LGND

  • Revenue, 12 months

    LGND$254M

    MRK$67.4B

    MRK is 265 times LGND

  • Net income, 12 months

    LGND$51M

    MRK$2.5B

    MRK is 48 times LGND

  • Operating margin

    LGND9.3%

    MRK–

  • ROIC

    LGND1.3%

    MRK3.9%

    2.6 points apart

  • P/E

    LGND111.2

    MRK133.9

    MRK is 1.2 times LGND

  • Dividend yield

    LGND0.0%

    MRK2.6%

    2.6 points apart

  • 5-year return

    LGND+186.2%

    MRK+86.3%

    99.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

LGND+186.2%

MRK+86.3%

10020030020222023202420252026
Returns by period
PeriodLGNDWith dividendsMRKWith dividends
1 year since November 18, 2025+38.6%Price +38.6%+41.8%Price +37.7%
3 years since November 17, 2023+396.3%+70.6% a yearPrice +396.3%+43.1%+12.7% a yearPrice +30.5%
5 years since November 18, 2021+186.2%+23.4% a yearPrice +186.2%+86.3%+13.2% a yearPrice +59.9%
10 years since November 21, 2016+328.7%+15.7% a yearPrice +328.7%+203.1%+11.7% a yearPrice +123.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

LGNDLigand PharmaceuticalsMRKMerck & Company

Valuation

LGNDMRK
Valuation
Price$286.94$132.81
Market value$5.7B$328B
Enterprise value (EV)$6.4B$372B
P/E111.2133.9
P/E, 5-year median30.814.8
P/B6.07.3
EV/EBIT271.478.2
Free cash flow yield1.6%4.5%

Results and growth

LGNDMRK
Results and growth
Revenue, 12 months$254M$67.4B
Net income, 12 months$51M$2.5B
Free cash flow, 12 months$91M$14.7B
Earnings per share, 12 months$2.30$0.98
Revenue growth, year on year60.4%1.3%
Revenue growth a year, past+10.4%over 5 years+9.4%over 5 years
EPS growth a year, past–+21.2%over 5 years

Margins and returns on capital

LGNDMRK
Margins and returns on capital
Gross margin–71.8%
Operating margin9.3%–
Net margin20.3%3.6%
ROIC1.3%3.9%
ROE5.3%5.2%

Balance sheet

LGNDMRK
Balance sheet
Cash$447M$9.7B
Total debt$1.2B$53.8B
Net debt / EBITDA11.95.7
Interest cover2.9×2.4×

Dividends and buybacks

LGNDMRK
Dividends and buybacks
Dividend yield–2.6%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield0.3%1.6%
Shareholder yield0.3%4.1%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: LGND or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, Ligand Pharmaceuticals or Merck & Company?

By market value, Merck & Company ($328B) is about 57.4 times Ligand Pharmaceuticals ($5.7B), at today's prices.

How did LGND and MRK stock do over the last 10 years?

Since November 21, 2016, LGND's price moved +328.7% and MRK's +123.4%. With dividends: LGND +328.7% (+15.7% a year), MRK +203.1% (+11.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, LGND or MRK?

The dividend yield at today's price is none for Ligand Pharmaceuticals and 2.56% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of LGND and MRK?

At today's price, the P/E is 111.2 for LGND and 133.9 for MRK. The median of the last five years was 30.8 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, Ligand Pharmaceuticals or Merck & Company?

Over the last twelve months, the net margin was 20.3% for Ligand Pharmaceuticals and 3.6% for Merck & Company, and the operating margin 9.3% and –. Revenue was $254M and $67.4B.

Which is the better investment, Ligand Pharmaceuticals or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.